These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28429248)

  • 41. A regional anticoagulation program improves safety and outcomes for both children and adults.
    Rodriguez V; Stanek J; Cua CL; Sankar A; Giver J; Monda K; Canini J; Dunn AL; Kerlin BA
    J Thromb Thrombolysis; 2023 Jul; 56(1):27-36. PubMed ID: 37093351
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of aspirin and warfarin therapy on thromboembolic events in patients with univentricular hearts and Fontan palliation.
    Potter BJ; Leong-Sit P; Fernandes SM; Feifer A; Mayer JE; Triedman JK; Walsh EP; Landzberg MJ; Khairy P
    Int J Cardiol; 2013 Oct; 168(4):3940-3. PubMed ID: 23870650
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Time in Therapeutic Range and Outcomes After Warfarin Initiation in Newly Diagnosed Atrial Fibrillation Patients With Renal Dysfunction.
    Szummer K; Gasparini A; Eliasson S; Ärnlöv J; Qureshi AR; Bárány P; Evans M; Friberg L; Carrero JJ
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28249846
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Warfarin-related outcomes in patients with antiphospholipid antibody syndrome managed in an anticoagulation clinic.
    Wittkowsky AK; Downing J; Blackburn J; Nutescu E
    Thromb Haemost; 2006 Aug; 96(2):137-41. PubMed ID: 16894455
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of medication timing on anticoagulation stability in users of warfarin (the INRange RCT): study protocol for a randomized controlled trial.
    Heran BS; Allan GM; Green L; Korownyk C; Kolber M; Olivier N; Flesher M; Garrison S
    Trials; 2016 Aug; 17(1):391. PubMed ID: 27488365
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Complications of warfarin therapy: causes, costs, and the role of the anticoagulation clinic.
    Hamby L; Weeks WB; Malikowski C
    Eff Clin Pract; 2000; 3(4):179-84. PubMed ID: 11183433
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA.
    Wieloch M; Själander A; Frykman V; Rosenqvist M; Eriksson N; Svensson PJ
    Eur Heart J; 2011 Sep; 32(18):2282-9. PubMed ID: 21616951
    [TBL] [Abstract][Full Text] [Related]  

  • 48. INR goal attainment and oral anticoagulation knowledge of patients enrolled in an anticoagulation clinic in a Veterans Affairs medical center.
    Baker JW; Pierce KL; Ryals CA
    J Manag Care Pharm; 2011 Mar; 17(2):133-42. PubMed ID: 21348546
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thromboembolic problems after the Fontan operation.
    Monagle P; Karl TR
    Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu; 2002; 5():36-47. PubMed ID: 11994863
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intensity of anticoagulation with warfarin and risk of adverse events in patients presenting to the emergency department.
    Anthony CJ; Karim S; Ackroyd-Stolarz S; Fry A; Murphy NG; Christie R; Zed PJ
    Ann Pharmacother; 2011 Jul; 45(7-8):881-7. PubMed ID: 21750309
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of chronic kidney disease on warfarin management in a pharmacist-managed anticoagulation clinic.
    Kleinow ME; Garwood CL; Clemente JL; Whittaker P
    J Manag Care Pharm; 2011 Sep; 17(7):523-30. PubMed ID: 21870893
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quality of anticoagulation with warfarin in patients with nonvalvular atrial fibrillation in the community setting.
    Han SY; Palmeri ST; Broderick SH; Hasselblad V; Rendall D; Stevens S; Tenaglia A; Velazquez E; Whellan D; Wagner G; Heitner JF
    J Electrocardiol; 2013; 46(1):45-50. PubMed ID: 23063241
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Performance outcomes of a pharmacist-managed anticoagulation clinic in the rural, resource-constrained setting of Eldoret, Kenya.
    Manji I; Pastakia SD; DO AN; Ouma MN; Schellhase E; Karwa R; Miller ML; Saina C; Akwanalo C
    J Thromb Haemost; 2011 Nov; 9(11):2215-20. PubMed ID: 21914124
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial.
    Healey JS; Eikelboom J; Douketis J; Wallentin L; Oldgren J; Yang S; Themeles E; Heidbuchel H; Avezum A; Reilly P; Connolly SJ; Yusuf S; Ezekowitz M;
    Circulation; 2012 Jul; 126(3):343-8. PubMed ID: 22700854
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacist-managed international normalized ratio patient self-testing is associated with increased time in therapeutic range in patients with left ventricular assist devices at an academic medical center.
    Bishop MA; Streiff MB; Ensor CR; Tedford RJ; Russell SD; Ross PA
    ASAIO J; 2014; 60(2):193-8. PubMed ID: 24577370
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reduced anticoagulation variability in patients on warfarin monitored with Fiix-prothrombin time associates with reduced thromboembolism: The Fiix-trial.
    Oskarsdóttir AR; Gudmundsdottir BR; Indridason OS; Lund SH; Arnar DO; Bjornsson ES; Magnusson MK; Jensdottir HM; Vidarsson B; Francis CW; Onundarson PT
    J Thromb Thrombolysis; 2017 May; 43(4):550-561. PubMed ID: 28214948
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Improving quality measurement for anticoagulation: adding international normalized ratio variability to percent time in therapeutic range.
    Razouki Z; Ozonoff A; Zhao S; Jasuja GK; Rose AJ
    Circ Cardiovasc Qual Outcomes; 2014 Sep; 7(5):664-9. PubMed ID: 25185245
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Management of Chinese patients on warfarin therapy in two models of anticoagulation service - a prospective randomized trial.
    Chan FW; Wong RS; Lau WH; Chan TY; Cheng G; You JH
    Br J Clin Pharmacol; 2006 Nov; 62(5):601-9. PubMed ID: 17061966
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Age-associated risks of prophylactic anticoagulation in the setting of hip fracture.
    Isaacs C; Paltiel O; Blake G; Beaudet M; Conochie L; Leclerc J
    Am J Med; 1994 Jun; 96(6):487-91. PubMed ID: 8017444
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Improving warfarin therapy through implementation of a hospital-based pharmacist managed clinic in Jamaica.
    Mckenzie JA; Wilson-Clarke C; Prout J; Campbell J; Douglas RD; Gossell-Williams M
    Pharm Pract (Granada); 2018; 16(4):1214. PubMed ID: 30637024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.